Jubilant Pharmova has announced that dividend payments for the financial year 2024-25 are being withheld for shareholders who have not complied with KYC (Know Your Customer) requirements. This action is in accordance with guidelines to ensure regulatory compliance. Impacted shareholders are requested to update their KYC details to facilitate the release of their dividend payments. The company has provided instructions on how to complete the KYC process.
Dividend Payment Update
Jubilant Pharmova announced on October 27, 2025, that it is withholding the final dividend payments for the financial year 2024-25 for those shareholders who have not yet completed their KYC verification. This is in line with the regulatory requirements that mandate updated KYC information for dividend payouts.
Impacted Shareholders and Action Required
The dividend payments are being withheld due to the non-submission of mandatory KYC documents. Shareholders are urged to update their KYC details with the company’s Registrar and Transfer Agent (RTA) to ensure the release of their dividend payments. The company emphasizes that updating KYC details is compulsory for receiving payments.
How to Update KYC
Shareholders must furnish specific documents to update their KYC:
* Form ISR-1 for KYC update, along with self-attested supporting documents.* Form ISR-2 for banker attestation of signature along with original cancelled cheque with your name(s) printed thereon or self-attested copy of bank passbook/statement.* Form SH-13 for updation of Nomination for the aforesaid folio.* Form ISR-3 for “Opt-out of the Nomination”.
The necessary forms can be downloaded from Jubilant Pharmova’s investor relations section of their website.
Contact Information
Shareholders can send self-attested hard copies of the required documents to Alankit Assignments Limited, the company’s RTA, at the provided address. For any queries, shareholders are advised to contact the RTA via phone or email. The details are: Alankit Assignments Limited, 205-208, Anar Kali Complex, Jhandewalan Extension, New Delhi -110 055, phone: +91 11 42541234, email: [email protected].
Source: BSE
